Derivation of iPSC lines from two patients with autism spectrum disorder carrying NRXN1α deletion (NUIGi041-A, NUIG041-B; NUIGi045-A) and one sibling control (NUIGi042-A, NUIGi042-B)
![Thumbnail](/xmlui/themes/Mirage2/images/white_rectangle.jpeg)
File Type:
PDFItem Type:
Journal ArticleDate:
2021Access:
openAccessCitation:
Ding, Y. and O'Brien, A. and de la Cruz, B.M. and Yang, M. and Fitzgerald, J. and Yang, G. and Li, W. and McInerney, V. and Krawczyk, J. and Lynch, S.A. and Howard, L. and Allen, N.M. and O'Brien, T. and Gallagher, L. and Shen, S., Derivation of iPSC lines from two patients with autism spectrum disorder carrying NRXN1α deletion (NUIGi041-A, NUIG041-B; NUIGi045-A) and one sibling control (NUIGi042-A, NUIGi042-B), Stem Cell Research, 52, 102222, 2021Download Item:
Abstract:
NRXN1 encodes thousands of splicing variants categorized into long NRXN1α, short NRXN1β and extremely short NRXN1γ, which exert differential roles in neuronal excitation/inhibition. NRXN1α deletions are common in autism spectrum disorder (ASD) and other neurodevelopmental/neuropsychiatric disorders. We derived induced pluripotent stem cells (iPSCs) from one sibling control and two ASD probands carrying NRXN1α+/-, using non-integrating Sendai viral method. All iPSCs highly expressed pluripotency markers and could be differentiated into ectodermal/mesodermal/endodermal cells. The genotype and karyotype of the iPSCs were validated by whole genome SNP array. The availability of the iPSCs offers an opportunity for understanding NRXN1α function in human neurons and in ASD.
Author's Homepage:
http://people.tcd.ie/lgallaghhttp://people.tcd.ie/lynchs17
Description:
PUBLISHEDcited By 0
Author: Gallagher, Louise; Lynch, Sally
Type of material:
Journal ArticleCollections
Series/Report no:
Stem Cell Research52
102222
Availability:
Full text availableDOI:
http://dx.doi.org/10.1016/j.scr.2021.102222Metadata
Show full item recordLicences: